# Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tolvaptan-a-selective-oral-vasopressin-v-sub-2-sub-receptor-antagonist-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert W. Schrier,Peter Groß,Mihai Gheorghiade,Tomás Berl,Joseph G. Verbalis,Frank S. Czerwiec,Cesare Orlandi |
| Citations | 1,216 |
| DOI | 10.1056/nejmoa065181 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa065181?articleTools=true |
| OpenAlex ID | https://openalex.org/W2120040647 |
| PMID | 17105757 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Peter Groß](https://scholariq.org/researchers/peter-gro/)
- [Frank S. Czerwiec](https://scholariq.org/researchers/frank-s-czerwiec/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)

## Paper topics

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.